AIM ImmunoTech Highlights Recent Media Coverage of Ampligen’s® Broad-Spectrum Antiviral and Biodefense Potential
AIM ImmunoTech emphasizes recent media coverage evidencing Ampligen's broad-spectrum antiviral capabilities, including its potential role in combating emerging viral threats and post-viral diseases like Long COVID. The company also underscores the expansion of its intellectual property portfolio and ongoing clinical programs focused on oncology app…